These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38269480)

  • 1. Recent Progress in Anti-Tumor Nanodrugs Based on Tumor Microenvironment Redox Regulation.
    Yao L; Zhu X; Shan Y; Zhang L; Yao J; Xiong H
    Small; 2024 Jun; 20(25):e2310018. PubMed ID: 38269480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.
    Chen Q; Liu G; Liu S; Su H; Wang Y; Li J; Luo C
    Trends Pharmacol Sci; 2018 Jan; 39(1):59-74. PubMed ID: 29153879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting ROS in cancer: rationale and strategies.
    Glorieux C; Liu S; Trachootham D; Huang P
    Nat Rev Drug Discov; 2024 Aug; 23(8):583-606. PubMed ID: 38982305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma.
    Liu Y; Zhou J; Li Q; Li L; Jia Y; Geng F; Zhou J; Yin T
    Adv Drug Deliv Rev; 2021 May; 172():80-103. PubMed ID: 33705874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Janus-faced tumor microenvironment and redox.
    Khramtsov VV; Gillies RJ
    Antioxid Redox Signal; 2014 Aug; 21(5):723-9. PubMed ID: 24512276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy.
    Wang Y; Deng T; Liu X; Fang X; Mo Y; Xie N; Nie G; Zhang B; Fan X
    Int J Nanomedicine; 2024; 19():6253-6277. PubMed ID: 38911497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Microenvironment-Enabled Nanotherapy.
    Wang L; Huo M; Chen Y; Shi J
    Adv Healthc Mater; 2018 Apr; 7(8):e1701156. PubMed ID: 29283221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
    Li M; Zhang F; Su Y; Zhou J; Wang W
    Life Sci; 2018 May; 201():37-44. PubMed ID: 29577880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The redox-active nanomaterial toolbox for cancer therapy.
    Ibañez IL; Notcovich C; Catalano PN; Bellino MG; Durán H
    Cancer Lett; 2015 Apr; 359(1):9-19. PubMed ID: 25597786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Therapy Strategies Based on Microenvironment-Specific Responsive Nanomaterials.
    Zhang Z; Ding C; Sun T; Wang L; Chen C
    Adv Healthc Mater; 2023 Aug; 12(20):e2300153. PubMed ID: 36933000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chiral inorganic nanomaterials in the tumor microenvironment: A new chapter in cancer therapy.
    Song X; Hao C; Li Y; Li Y; Dong H; Wei Q; Wei M; Li H; Zhao L
    Pharmacol Res; 2024 Oct; 208():107386. PubMed ID: 39216840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy.
    Sun W; Xie S; Liu SF; Hu X; Xing D
    Int J Nanomedicine; 2024; 19():3919-3942. PubMed ID: 38708176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
    Jia M; Zhang D; Zhang C; Li C
    J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
    Sa P; Sahoo SK; Dilnawaz F
    Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotherapy Targeting the Tumor Microenvironment.
    Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
    Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of arsenic-metal complexes loaded nanodrugs for solid tumor therapy: A mini review.
    Fei W; Li C; Tao J; Cai X; Yao W; Ye Y; Zhang Y; Yao Y; Song Q; Li F; Zheng C
    Int J Pharm; 2020 Jun; 583():119385. PubMed ID: 32376447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinforcing vascular normalization therapy with a bi-directional nano-system to achieve therapeutic-friendly tumor microenvironment.
    Deng Y; Jiang Z; Jin Y; Qiao J; Yang S; Xiong H; Yao J
    J Control Release; 2021 Dec; 340():87-101. PubMed ID: 34662587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy.
    Lee S; Lee SA; Shinn J; Lee Y
    Int J Nanomedicine; 2024; 19():4893-4906. PubMed ID: 38828202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsive and activable nanomedicines for remodeling the tumor microenvironment.
    Zhang Y; Han X; Nie G
    Nat Protoc; 2021 Jan; 16(1):405-430. PubMed ID: 33311713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.